Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib

Por Schuler, Martin, Fischer, Jürgen R., Grohé, Christian, Gütz, Sylvia, Thomas, Michael, Kimmich, Martin, Schneider, Claus-Peter, Laack, Eckart, Märten, Angela
Publicado em 2014

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung...

Por Ramalingam, Suresh S., Spigel, David R., Chen, David, Steins, Martin B., Engelman, Jeffrey A., Schneider, Claus-Peter, Novello, Silvia, Eberhardt, Wilfried E.E., Crino, Lucio, Habben, Kai, Liu, Lian, Jänne, Pasi A., Brownstein, Carrie M., Reck, Martin
Publicado no J Clin Oncol (2011)